At a glance
ClinicalIndex Comparison RecordN/ACompleted· 438 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
International, Multicentre, Observational, Prospective, Longitudinal Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort (AboLiSh)
In Brief
An observational study for Adult Lower Limb Spasticity. Completed, enrolled 438 participants across 51 sites in 9 countries.
Detailed Summary
The purpose of the protocol is to assess the longitudinal attainment of person-centered and function related goals of patients who receive AbobotulinumtoxinA (aboBoNT-A) injections for adult lower limb spasticity over a period of 16 months.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAdult Lower Limb Spasticity
CountriesAustralia, Brazil, Canada, France, Germany, Italy, Poland, Russia, United States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedAug 2019
Enrollment StartDec 2019
Primary CompletionJul 2022
TodayJul 2026
First PostedAug 8, 2019
Enrollment StartDec 19, 2019
Primary CompletionJul 29, 2022
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 6.9 years ago